NCT07259382

Brief Summary

The primary goal of this proposal is to improve the understanding of the mechanisms causing persistent pain and disability in elbow fracture patients and their associated functional limitations. The specific objectives are as follows for elbow fractures: 1\) To describe NI mechanisms using biomarkers; 2) To identify factors related to increased NI biomarkers level; 3) To describe the associations between NI and outcomes; 4) To use these findings to refine a larger fully powered prognostic cohort study Hypotheses

  1. 1.Level of neuro-inflammation (NI) biomarkers\* will be significantly higher in patients presenting with both elbow fracture and CNS injury or PNI.
  2. 2.Consumption of opioid in mg of morphine equivalent will be higher in patients with a higher level of NI biomarkers.
  3. 3.Function, assessed by validated joint and limb specific functional questionnaires and QoL will be worse in patients with a higher level of NI biomarkers.
  4. 4.Chronic pain at 3 months will be higher (McGill Pain questionnaire V2, Neuropathic pain questionnaire, NPRS) in patients with a higher level of NI biomarkers.
  5. 5.Duration of tourniquet use and nerve dissection will be correlated to elbow fracture outcome with a higher level of NI biomarkers.
  6. 6.Target biomarkers based on preliminary study will include, but not be limited to: TNFa, IL6, Substance P, IL-1B, TREM-2, IL-16, CCL22, VEGF-a, BMPs (table 1).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
56mo left

Started Jun 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jun 2026Dec 2030

First Submitted

Initial submission to the registry

September 16, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 2, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

2.6 years

First QC Date

September 16, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

BiomarkersElbow fractureelbow dislocationNerve injuryTBI

Outcome Measures

Primary Outcomes (1)

  • Biomarkers

    Five blood samples per subject will be taken at selected intervals to measure the serum levels of the targeted pro-inflammatory cytokines for the 60 selected patients. A blood sample will be collected at the first appointment before surgery. Preoperative and postoperative blood samples will also be collected in the operating room. The first will be taken before skin asepsis and the second will be taken immediately after application of the final wound dressing. Blood from the fracture site (hematoma) will also be collected when possible. The fifth blood sample will be collected at 3 months of follow up. Samples will be stored in a -70°C freezer in each city and sent every 6 months for analysis to Olink, Montreal. Group dosage will be performed for the NI factors and circulating proteins (e.g. cytokines, chemokines, neuropeptides), such as TNF, IL-1, IL-6, IL-16, osteopontin, S100B, NSE, GFAP, Substance P, TREM-2, CCL22, and BMPs.

    Baseline, preoperative, perioperative, immediatly after the intervention, 3months

Secondary Outcomes (10)

  • PREE

    Baseline, preop, 2 weeks, 3-6-12 months

  • Range of motion

    Baseline, preop, immediatly after the procedure, 2 weeks, 3-6-12months

  • Pain assessment

    Baseline, preop, 2 weeks, 3-6-12 months

  • Opioïds consumption

    Recorded once per day from baseline through 12months

  • Quick-DASH

    Baseline, preop, 2weeks, 3 months, 6 months, 12 months

  • +5 more secondary outcomes

Study Arms (3)

Elbow fracture

Patient with an acute, isolated elbow fracture

Other: Biomarkers evaluation

Elbow fracture and peripheral nerve injury

Patient with an acute elbow fracture and a peripheral nerve injury

Other: Biomarkers evaluation

Ebow fracture and TBI

Patient with an acute elbow fracture and a mild TBI

Other: Biomarkers evaluation

Interventions

Participants will undergo blood test that evaluate several inflammatory biomarkers before and after the surgery

Ebow fracture and TBIElbow fractureElbow fracture and peripheral nerve injury

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with an acute elbow surgery with an appointment at the Hôpital du Sacré-Coeur de Montréal

You may qualify if:

  • Adults 18 years or older with an acute elbow fracture and/or dislocation less than a week old
  • Open surgery as the chosen treatment

You may not qualify if:

  • Patient with a history of ipsilateral upper limb trauma or pathology, neurological disorder.
  • Patient unable to answer questionnaires.
  • Patient unavailable for a one-year follow-up, for example from another country.
  • Patient with vascular injury or open fracture
  • Patient with an active inflammatory disease (ex: rheumatoid arthritis)
  • Patient using anti-inflammatory drugs or immunosuppressants at the time of the injury.
  • Patient with another acute ipsilateral injury to the upper limb
  • Polytrauma patients with other injuries than the elbow fracture and concomitant central or peripheral neurological injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (59)

  • Mahabier KC, Hartog DD, Van Veldhuizen J, Panneman MJ, Polinder S, Verhofstad MH, Van Lieshout EM. Trends in incidence rate, health care consumption, and costs for patients admitted with a humeral fracture in The Netherlands between 1986 and 2012. Injury. 2015 Oct;46(10):1930-7. doi: 10.1016/j.injury.2015.07.025. Epub 2015 Aug 4.

    PMID: 26296455BACKGROUND
  • Jodoin M, Rouleau DM, Therrien E, Chauny JM, Sandman E, Larson-Dupuis C, Leduc S, Gosselin N, De Beaumont L. Investigating the incidence and magnitude of heterotopic ossification with and without joints involvement in patients with a limb fracture and mild traumatic brain injury. Bone Rep. 2019 Aug 13;11:100222. doi: 10.1016/j.bonr.2019.100222. eCollection 2019 Dec.

  • Chapleau J, Canet F, Petit Y, Sandman E, Laflamme GY, Rouleau DM. Demographic and anthropometric factors affecting elbow range of motion in healthy adults. J Shoulder Elbow Surg. 2013 Jan;22(1):88-93. doi: 10.1016/j.jse.2012.05.028. Epub 2012 Sep 1.

  • Rouleau DM, Sandman E, van Riet R, Galatz LM. Management of fractures of the proximal ulna. J Am Acad Orthop Surg. 2013 Mar;21(3):149-60. doi: 10.5435/JAAOS-21-03-149.

  • Thabane L, Lancaster G. A guide to the reporting of protocols of pilot and feasibility trials. Pilot Feasibility Stud. 2019 Feb 28;5:37. doi: 10.1186/s40814-019-0423-8. eCollection 2019.

  • Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016 Oct;12(10):563-74. doi: 10.1038/nrneurol.2016.127. Epub 2016 Sep 16.

  • Niezgoda A, Michalak S, Losy J, Kalinowska-Lyszczarz A, Kozubski W. sNCAM as a specific marker of peripheral demyelination. Immunol Lett. 2017 May;185:93-97. doi: 10.1016/j.imlet.2017.03.011. Epub 2017 Mar 21.

  • Oh YM, Ma TZ, Kwak YG, Eun JP. Proteomic evaluation to identify biomarkers for carpal tunnel syndrome: a comparative serum analysis. Connect Tissue Res. 2013;54(1):76-81. doi: 10.3109/03008207.2012.746320. Epub 2012 Dec 3.

  • Michetti F, D'Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, Geloso MC. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019 Jan;148(2):168-187. doi: 10.1111/jnc.14574. Epub 2018 Nov 12.

  • Bergquist ER, Hammert WC. Timing and appropriate use of electrodiagnostic studies. Hand Clin. 2013 Aug;29(3):363-70. doi: 10.1016/j.hcl.2013.04.005. Epub 2013 Jun 12.

  • Seddon HJ. A Classification of Nerve Injuries. Br Med J. 1942 Aug 29;2(4260):237-9. doi: 10.1136/bmj.2.4260.237. No abstract available.

  • Packham TL, Spicher CJ, MacDermid JC, Quintal I, Buckley N. Evaluating a sensitive issue: reliability of a clinical evaluation for allodynia severity. Somatosens Mot Res. 2020 Mar;37(1):22-27. doi: 10.1080/08990220.2019.1704242. Epub 2019 Dec 20.

  • Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KC, Geertzen JH; CRPS I task force. Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol. 2010 Mar 31;10:20. doi: 10.1186/1471-2377-10-20.

  • Houdek MT, Shin AY. Management and complications of traumatic peripheral nerve injuries. Hand Clin. 2015 May;31(2):151-63. doi: 10.1016/j.hcl.2015.01.007. Epub 2015 Feb 28.

  • King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995 Sep;242(9):587-92. doi: 10.1007/BF00868811.

  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81-4. doi: 10.1016/s0140-6736(74)91639-0. No abstract available.

  • Nazari G, MacDermid JC, Bain J, Levis CM, Thoma A. Estimation of health-related-quality of life depends on which utility measure is selected for patients with carpal tunnel syndrome. J Hand Ther. 2017 Jul-Sep;30(3):299-306. doi: 10.1016/j.jht.2016.11.001. Epub 2016 Dec 14.

  • Cook KF, Dunn W, Griffith JW, Morrison MT, Tanquary J, Sabata D, Victorson D, Carey LM, Macdermid JC, Dudgeon BJ, Gershon RC. Pain assessment using the NIH Toolbox. Neurology. 2013 Mar 12;80(11 Suppl 3):S49-53. doi: 10.1212/WNL.0b013e3182872e80.

  • Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May;92(1-2):147-57. doi: 10.1016/s0304-3959(00)00482-6.

  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.

  • Lovejoy TI, Turk DC, Morasco BJ. Evaluation of the psychometric properties of the revised short-form McGill Pain Questionnaire. J Pain. 2012 Dec;13(12):1250-7. doi: 10.1016/j.jpain.2012.09.011.

  • Fayad F, Lefevre-Colau MM, Gautheron V, Mace Y, Fermanian J, Mayoux-Benhamou A, Roren A, Rannou F, Roby-Brami A, Revel M, Poiraudeau S. Reliability, validity and responsiveness of the French version of the questionnaire Quick Disability of the Arm, Shoulder and Hand in shoulder disorders. Man Ther. 2009 Apr;14(2):206-12. doi: 10.1016/j.math.2008.01.013. Epub 2008 Apr 23.

  • Beauchemin G, MacDermid JC, Bourduas K, Poirier MF, Gaudelli C, Rouleau DM. Translation and validation of the PREE (Patient Rated Elbow Evaluation) to a French version. Orthop Traumatol Surg Res. 2015 Jun;101(4):405-9. doi: 10.1016/j.otsr.2015.03.012. Epub 2015 Apr 27.

  • Vincent JI, MacDermid JC, King GJ, Grewal R. Rasch analysis of the Patient Rated Elbow Evaluation questionnaire. Health Qual Life Outcomes. 2015 Jun 20;13:84. doi: 10.1186/s12955-015-0275-8.

  • de Mos M, Laferriere A, Millecamps M, Pilkington M, Sturkenboom MC, Huygen FJ, Coderre TJ. Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain. 2009 Nov;10(11):1161-9. doi: 10.1016/j.jpain.2009.04.012.

  • van der Velde J, Serfontein L, Iohom G. Reducing the potential for tourniquet-associated reperfusion injury. Eur J Emerg Med. 2013 Dec;20(6):391-6. doi: 10.1097/MEJ.0b013e3283591668.

  • Konrad G, Markmiller M, Lenich A, Mayr E, Ruter A. Tourniquets may increase postoperative swelling and pain after internal fixation of ankle fractures. Clin Orthop Relat Res. 2005 Apr;(433):189-94. doi: 10.1097/01.blo.0000151849.37260.0a.

  • Kruse H, Christensen KP, Moller AM, Gogenur I. Tourniquet use during ankle surgery leads to increased postoperative opioid use. J Clin Anesth. 2015 Aug;27(5):380-4. doi: 10.1016/j.jclinane.2015.03.034. Epub 2015 May 12.

  • Shearin JW, Chapman TR, Miller A, Ilyas AM. Ulnar Nerve Management with Distal Humerus Fracture Fixation: A Meta-Analysis. Hand Clin. 2018 Feb;34(1):97-103. doi: 10.1016/j.hcl.2017.09.010.

  • Stewart AN, Lowe JL, Glaser EP, Mott CA, Shahidehpour RK, McFarlane KE, Bailey WM, Zhang B, Gensel JC. Acute inflammatory profiles differ with sex and age after spinal cord injury. J Neuroinflammation. 2021 May 13;18(1):113. doi: 10.1186/s12974-021-02161-8.

  • Olivecrona C, Ponzer S, Hamberg P, Blomfeldt R. Lower tourniquet cuff pressure reduces postoperative wound complications after total knee arthroplasty: a randomized controlled study of 164 patients. J Bone Joint Surg Am. 2012 Dec 19;94(24):2216-21. doi: 10.2106/JBJS.K.01492.

  • Du H, Shi J, Wang M, An S, Guo X, Wang Z. Analyses of gene expression profiles in the rat dorsal horn of the spinal cord using RNA sequencing in chronic constriction injury rats. J Neuroinflammation. 2018 Sep 25;15(1):280. doi: 10.1186/s12974-018-1316-0.

  • Guo TZ, Wei T, Huang TT, Kingery WS, Clark JD. Oxidative Stress Contributes to Fracture/Cast-Induced Inflammation and Pain in a Rat Model of Complex Regional Pain Syndrome. J Pain. 2018 Oct;19(10):1147-1156. doi: 10.1016/j.jpain.2018.04.006. Epub 2018 Apr 30.

  • Uceyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007 Nov;132(1-2):195-205. doi: 10.1016/j.pain.2007.07.031. Epub 2007 Sep 24.

  • Schmid AB, Coppieters MW, Ruitenberg MJ, McLachlan EM. Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats. J Neuropathol Exp Neurol. 2013 Jul;72(7):662-80. doi: 10.1097/NEN.0b013e318298de5b.

  • Schlereth T, Drummond PD, Birklein F. Inflammation in CRPS: role of the sympathetic supply. Auton Neurosci. 2014 May;182:102-7. doi: 10.1016/j.autneu.2013.12.011. Epub 2013 Dec 22.

  • Block L. Glial dysfunction and persistent neuropathic postsurgical pain. Scand J Pain. 2016 Jan;10:74-81. doi: 10.1016/j.sjpain.2015.10.002. Epub 2015 Nov 13.

  • Liu XG, Pang RP, Zhou LJ, Wei XH, Zang Y. Neuropathic Pain: Sensory Nerve Injury or Motor Nerve Injury? Adv Exp Med Biol. 2016;904:59-75. doi: 10.1007/978-94-017-7537-3_5.

  • Moreau N, Mauborgne A, Bourgoin S, Couraud PO, Romero IA, Weksler BB, Villanueva L, Pohl M, Boucher Y. Early alterations of Hedgehog signaling pathway in vascular endothelial cells after peripheral nerve injury elicit blood-nerve barrier disruption, nerve inflammation, and neuropathic pain development. Pain. 2016 Apr;157(4):827-839. doi: 10.1097/j.pain.0000000000000444.

  • Martins RS, Bastos D, Siqueira MG, Heise CO, Teixeira MJ. Traumatic injuries of peripheral nerves: a review with emphasis on surgical indication. Arq Neuropsiquiatr. 2013 Oct;71(10):811-4. doi: 10.1590/0004-282X20130127.

  • Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, Hasler LM, Wild K, Skodras A, Blank T, Staszewski O, Datta M, Centeno TP, Capece V, Islam MR, Kerimoglu C, Staufenbiel M, Schultze JL, Beyer M, Prinz M, Jucker M, Fischer A, Neher JJ. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018 Apr;556(7701):332-338. doi: 10.1038/s41586-018-0023-4. Epub 2018 Apr 11.

  • Kanefsky R, Motamedi V, Mithani S, Mysliwiec V, Gill JM, Pattinson CL. Mild traumatic brain injuries with loss of consciousness are associated with increased inflammation and pain in military personnel. Psychiatry Res. 2019 Sep;279:34-39. doi: 10.1016/j.psychres.2019.07.001. Epub 2019 Jul 2.

  • Cairns BE, Arendt-Nielsen L, Sacerdote P. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain? Scand J Pain. 2015 Jan 1;6(1):3-6. doi: 10.1016/j.sjpain.2014.10.002.

  • Jodoin M, Rouleau DM, Gosselin N, Benoit B, Leduc S, Laflamme Y, Larson-Dupuis C, De Beaumont L. Comorbid mild traumatic brain injury increases pain symptoms in patients suffering from an isolated limb fracture. Injury. 2017 Sep;48(9):1927-1931. doi: 10.1016/j.injury.2017.06.025. Epub 2017 Jul 1.

  • Worden A, Ilyas AM. Ulnar neuropathy following distal humerus fracture fixation. Orthop Clin North Am. 2012 Oct;43(4):509-14. doi: 10.1016/j.ocl.2012.07.019. Epub 2012 Aug 30.

  • Mathew PK, Athwal GS, King GJ. Terrible triad injury of the elbow: current concepts. J Am Acad Orthop Surg. 2009 Mar;17(3):137-51. doi: 10.5435/00124635-200903000-00003.

  • Jodoin M, Rouleau DM, Charlebois-Plante C, Benoit B, Leduc S, Laflamme GY, Gosselin N, Larson-Dupuis C, De Beaumont L. Incidence rate of mild traumatic brain injury among patients who have suffered from an isolated limb fracture: Upper limb fracture patients are more at risk. Injury. 2016 Aug;47(8):1835-40. doi: 10.1016/j.injury.2016.05.036. Epub 2016 May 27.

  • Hansson E. Long-term pain, neuroinflammation and glial activation. Scand J Pain. 2010 Apr 1;1(2):67-72. doi: 10.1016/j.sjpain.2010.01.002.

  • Teunis T, Stoop N, Park CJ, Ring D. What factors are associated with a second opioid prescription after treatment of distal radius fractures with a volar locking plate? Hand (N Y). 2015 Dec;10(4):639-48. doi: 10.1007/s11552-015-9767-6. Epub 2015 Apr 30.

  • Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction. Ann Emerg Med. 2016 Aug;68(2):202-8. doi: 10.1016/j.annemergmed.2015.11.033. Epub 2016 Feb 11.

  • King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014 Aug;104(8):e32-42. doi: 10.2105/AJPH.2014.301966. Epub 2014 Jun 12.

  • Hina N, Fletcher D, Poindessous-Jazat F, Martinez V. Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study. Eur J Anaesthesiol. 2015 Apr;32(4):255-61. doi: 10.1097/EJA.0000000000000197.

  • Bot AG, Bekkers S, Arnstein PM, Smith RM, Ring D. Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief. Clin Orthop Relat Res. 2014 Aug;472(8):2542-9. doi: 10.1007/s11999-014-3660-4. Epub 2014 Apr 29.

  • Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019 Apr 13;393(10180):1537-1546. doi: 10.1016/S0140-6736(19)30352-6.

  • Grobet C, Marks M, Tecklenburg L, Audige L. Application and measurement properties of EQ-5D to measure quality of life in patients with upper extremity orthopaedic disorders: a systematic literature review. Arch Orthop Trauma Surg. 2018 Jul;138(7):953-961. doi: 10.1007/s00402-018-2933-x. Epub 2018 Apr 13.

  • de Putter CE, Selles RW, Polinder S, Panneman MJ, Hovius SE, van Beeck EF. Economic impact of hand and wrist injuries: health-care costs and productivity costs in a population-based study. J Bone Joint Surg Am. 2012 May 2;94(9):e56. doi: 10.2106/JBJS.K.00561.

  • Dietrich M, Wasmer M, Platz A, Spross C. Return-to-Work Following Open Reduction and Internal Fixation of Proximal Humerus Fractures. Open Orthop J. 2014 Sep 15;8:281-7. doi: 10.2174/1874325001408010281. eCollection 2014.

  • Fuzier R, Rousset J, Bataille B, Salces-y-Nedeo A, Magues JP. One half of patients reports persistent pain three months after orthopaedic surgery. Anaesth Crit Care Pain Med. 2015 Jun;34(3):159-64. doi: 10.1016/j.accpm.2014.09.006. Epub 2015 May 23.

  • Tunali O, Ersen A, Pehlivanoglu T, Bayram S, Atalar AC, Demirhan M. Evaluation of risk factors for stiffness after distal humerus plating. Int Orthop. 2018 Apr;42(4):921-926. doi: 10.1007/s00264-018-3792-3. Epub 2018 Feb 1.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Bloodtest

MeSH Terms

Conditions

Elbow FracturesBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Elbow InjuriesArm InjuriesWounds and InjuriesFractures, BoneBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous System

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic surgeon

Study Record Dates

First Submitted

September 16, 2025

First Posted

December 2, 2025

Study Start

June 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2030

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share